Ranked by engagement
Top topics — this quarter page 13
Ranked by replies, likes and views over this quarter, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
515 topics · page 13 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] Documenting an adverse event properly
Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published trials in this…
|
+18 | 22 | 4.3k | 1d |
|
Substitution between formats during a shortage — what changed since
Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+17 | 21 | 2.7k | 9d |
|
Talking to a therapist about this specifically
Posting this under the heading it deserves: Talking to a therapist about this specifically Everything below is what sits behind that. Asking about a population rather than about a person. The published trials…
|
+20 | 24 | 855 | 14h |
|
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med ,…
|
+18 | 22 | 656 | 13h |
|
GIP receptor agonism and the argument about direction — does this still hold?
GIP receptor agonism and the argument about direction — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic…
|
+10 | 14 | 15k | 16h |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+17 | 22 | 4.5k | 1d |
|
Rewriting my first post: a before-and-after, with commentary — what changed since
Posting this under the heading it deserves: Rewriting my first post: a before-and-after, with commentary — what changed since Everything below is what sits behind that. I want to check my reasoning rather…
|
+15 | 19 | 12k | 13h |
|
Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I…
|
+16 | 20 | 3.1k | 11h |
|
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med ,…
|
+10 | 14 | 8.4k | 16h |
|
Second pass at: I joined for one answer and stayed for a year — what changed my mind
Second pass at: I joined for one answer and stayed for a year — what changed my mind — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have…
|
4 | 25k | 2mo | |
|
Cleaning a self-reported dataset and what you throw away
Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
2 | 28k | 1d | |
|
Where to report an adverse event officially, by region
Where to report an adverse event officially, by region Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
2 | 27k | 1h | |
|
Deletion sequences: expected mass shifts by residue — the long version
On the subject in the title: Deletion sequences: expected mass shifts by residue — the long version Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+21 | 25 | 6.9k | 10h |
|
About the Mass spectrometry category
LC-MS and high-resolution MS, charge states, mass accuracy in ppm, and what identity confirmation does and does not establish. This post is a community wiki: any member at trust level 3 or above can edit it,…
|
+5 | 9 | 19k | 6h |
|
Coming back to: Batch date after test date, and other internal inconsistencies
On the subject in the title: Batch date after test date, and other internal inconsistencies Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+21 | 27 | 420 | 3h |
|
HbA1c lag and what it can and cannot tell you at eight weeks — one year on
Posting this under the heading it deserves: HbA1c lag and what it can and cannot tell you at eight weeks — one year on Everything below is what sits behind that. General question, not a request for advice…
|
+18 | 22 | 655 | 13h |
|
Semaglutide and alcohol: what is actually documented
Posting this under the heading it deserves: Semaglutide and alcohol: what is actually documented Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of a claim I do…
|
+14 | 18 | 10k | 2d |
|
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
|
+15 | 19 | 2.8k | 1d |
|
When a network meta-analysis is defensible and when it is not
When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with LEADER (…
|
2 | 27k | 4h | |
|
Why the cheapest option is often not the cheapest
Why the cheapest option is often not the cheapest I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in this…
|
+19 | 23 | 1.2k | 12h |
|
Language barriers in accessing a prescription abroad
Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
|
2 | 22k | 1h | |
|
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case…
|
+18 | 22 | 2k | 25d |
|
The five documentation pages worth reading before you post anything — a second dataset
On the subject in the title: The five documentation pages worth reading before you post anything — a second dataset Working notes rather than a conclusion. Question in the title. Context below, and I have…
|
2 | 24k | 1d | |
|
Reading a syringe in poor light, and how to avoid needing to
Reading a syringe in poor light, and how to avoid needing to Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen…
|
2 | 22k | just now | |
|
What other technical communities get right that we do not
What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. Lower-stakes topic, but the sourcing rule still applies if…
|
+2 | 6 | 23k | 5h |
|
Coming back to: Why our vendor pages link the storefront and mark it sponsored
Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
2 | 22k | 8h | |
|
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+19 | 23 | 311 | 12d |
|
Journal club: STEP 3 and the intensive behavioural therapy floor
Posting this under the heading it deserves: Journal club: STEP 3 and the intensive behavioural therapy floor Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with STEP 4 (…
|
+6 | 10 | 13k | 28d |
|
Fibre intake when total intake falls, and the constipation link — one year on
Posting this under the heading it deserves: Fibre intake when total intake falls, and the constipation link — one year on Everything below is what sits behind that. Longitudinal report with the method stated,…
|
+9 | 13 | 16k | 16h |
|
Subgroup analyses: pre-specified versus discovered
Subgroup analyses: pre-specified versus discovered — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURPASS-4 ( Lancet , 2021) and finding the…
|
2 | 27k | 1d |